These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 8166179)
1. How to use the new CVVH renal replacement systems. Dirkes S Am J Nurs; 1994 May; 94(5):67-73. PubMed ID: 8166179 [No Abstract] [Full Text] [Related]
2. 24 hour CVVH treatment on the intensive care unit: a reality. Hameleers P EDTNA ERCA J; 1998; 24(4):21-2. PubMed ID: 10222910 [TBL] [Abstract][Full Text] [Related]
3. Setting up a continuous venovenous hemofiltration educational program. A case study in program development. Clevenger K Crit Care Nurs Clin North Am; 1998 Jun; 10(2):235-44. PubMed ID: 9764017 [TBL] [Abstract][Full Text] [Related]
5. Educational programme for staff implementing a new renal replacement therapy. Jones AE; Howard C EDTNA ERCA J; 1997; 23(2):33-7. PubMed ID: 9663993 [TBL] [Abstract][Full Text] [Related]
6. Adult/pediatric CVVH. The pump, the patient, the circuit. Headrick CL Crit Care Nurs Clin North Am; 1998 Jun; 10(2):197-207. PubMed ID: 9764013 [No Abstract] [Full Text] [Related]
7. CVVH in postoperative care of liver transplantation. Fiore G; Donadio PP; Gianferrari P; Santacroce C; Guermani A Minerva Anestesiol; 1998 Mar; 64(3):83-7. PubMed ID: 9677792 [TBL] [Abstract][Full Text] [Related]
8. Continuous veno-venous hemofiltration in Bhumibol Adulyadej Hospital. Chuasuwan A; Gojaseni P; Chittinandana A J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S86-97. PubMed ID: 17044459 [TBL] [Abstract][Full Text] [Related]
9. Comparison of polyacrylonitrile (AN69) and polysulphone membrane during hemofiltration in canine endotoxic shock. Rogiers P; Zhang H; Pauwels D; Vincent JL Crit Care Med; 2003 Apr; 31(4):1219-25. PubMed ID: 12682496 [TBL] [Abstract][Full Text] [Related]
10. Post-coronarography application of continuous veno-venous hemofiltration in the prevention of contrast nephropathy in patients with complex multisystem deficiency. La Manna G; Pancaldi L; Dalmastri V; Cuna V; Capecchi A; Comai G; Persici E; Bacchi G; Cianciolo G; Lombardi A; Marrozzini C; Colì L; Stefoni S In Vivo; 2008; 22(1):123-9. PubMed ID: 18396794 [TBL] [Abstract][Full Text] [Related]
11. Continuous venovenous hemofiltration with citrate-based replacement fluid: efficacy, safety, and impact on nutrition. Bihorac A; Ross EA Am J Kidney Dis; 2005 Nov; 46(5):908-18. PubMed ID: 16253732 [TBL] [Abstract][Full Text] [Related]
12. Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients. Thoenen M; Schmid ER; Binswanger U; Schuepbach R; Aerne D; Schmidlin D Wien Klin Wochenschr; 2002 Feb; 114(3):108-14. PubMed ID: 12060967 [TBL] [Abstract][Full Text] [Related]
13. Continuous renal replacement therapy: evolution in technology and current nomenclature. Ronco C; Bellomo R Kidney Int Suppl; 1998 May; 66():S160-4. PubMed ID: 9573595 [TBL] [Abstract][Full Text] [Related]
14. Continuous veno-venous hemofiltration for the treatment of contrast-induced acute renal failure after percutaneous coronary interventions. Marenzi G; Bartorelli AL; Lauri G; Assanelli E; Grazi M; Campodonico J; Marana I Catheter Cardiovasc Interv; 2003 Jan; 58(1):59-64. PubMed ID: 12508197 [TBL] [Abstract][Full Text] [Related]
15. Chronic single needle predilutional haemofiltration in a pre-school child. Buturović JB; Calić M; Ponikvar RR; Gucek AM; Kenda RB EDTNA ERCA J; 1996; 22(4):22-3. PubMed ID: 10723343 [TBL] [Abstract][Full Text] [Related]
16. Hydroxyethyl starch 130 kd/0.4 and albumin improve CVVH biocompatibility whereas gelatin and hydroxyethyl starch 200 kd/0.5 lead to adverse side effects of CVVH in anesthetized pigs. Unger JK; Haltern C; Kobela JB; Francis R; Rossaint R; Grosse-Siestrup C Shock; 2006 May; 25(5):533-45. PubMed ID: 16680020 [TBL] [Abstract][Full Text] [Related]
17. Collaborative development of a patient simulator for educating nurses in hemofiltration therapies. Talbot TL; Rosenthal CH; Strider VC Biomed Instrum Technol; 1994; 28(4):271-81. PubMed ID: 7920844 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of enoxaparin removal by continuous renal replacement therapies with acrylonitrile and polysulfone membranes. Isla A; Gascón AR; Maynar J; Arzuaga A; Corral E; Martín A; Solinís MA; Muñoz JL Clin Ther; 2005 Sep; 27(9):1444-51. PubMed ID: 16291417 [TBL] [Abstract][Full Text] [Related]